Metallo-β-lactamase inhibitors with β-lactam and metal chelate structures
Identify platinum-resistant ovarian cancer patients using EV-miRNA markers in body fluids and treat …
Therapeutic and Prophylactic Drugs for Idiopathic Osteonecrosis of the Femoral Head (ONFH)
Therapeutic target molecules and antisense oligonucleic acid (ASO) therapeutic agents for autosomal …
Identification of biomarkers in vitreous humor of Toxoplasma gondii migrating into the eye, and deve…
Discovery of mGluR5 dysfunction in ALS patients with TDP-43 pathology offers a new direction for the…
This antisense oligonucleotide (ASO) sterically blocks the binding hotspots of RNA-binding proteins …
Selectively activating G-protein signaling to reduce side effects and enhance analgesic efficacy.
This page is currently available only in Japanese.
Small molecule compounds (CRY1-A and CRY2-A) that selectively inhibit and activate the circadian clo…